SHNUF yields 10.00% · MRK yields 2.76%● Live data
📍 SHNUF pulled ahead of the other in Year 1
Combined, SHNUF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SHNUF + MRK for your $10,000?
Intouch Holdings Public Company Limited, through its subsidiaries, engages in the satellite, Internet, telecommunications, and media and advertising businesses. It operates through Local Wireless Telecommunications, Satellite and International Businesses, and Other Businesses segments. The company offers transponder rental and related services for domestic and international communications; broadband content services; satellite uplink-downlink, broadcasting television and telecommunication services; Internet data center, Internet, and telecommunication services; advertising, insurance broker, and other related services; and sale and service related to media, telephone network, mobile content, and engineering development services on communication technology and electronics. It also sells user terminals of IPSTAR and direct television equipment; and distributes internet equipment. In addition, the company offers local mobile telecommunication services; provides computer program and related services, as well as information technology and home shopping services; and trades in and rents telecommunications equipment and accessories. It has operations in Thailand, Australia, India, Japan, Myanmar, Malaysia, and internationally. The company was formerly known as Shin Corporation Public Company Limited and changed its name to Intouch Holdings Public Company Limited in March 2014. Intouch Holdings Public Company Limited was founded in 1983 and is based in Bangkok, Thailand. As of December 31, 2021, Intouch Holdings Public Company Limited operates as a subsidiary of Gulf Energy Development Public Company Limited.
Full SHNUF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.